Clinical trial
Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria
NCT00344006 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00344006 |
|---|---|
| Title | Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria |
| Official title | A Multi-centre, Randomised, Double-blind, Double Dummy Study Comparing the Efficacy and Safety of Chlorproguanil-dapsone-artesunate Versus Artemether-lumefantrine in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Children and Adolescents in Africa. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum |
| Intervention type | Drug |
| Interventions | chlorproguanil-dapsone-artesunate, artemether-lumefantrine |
| Enrollment | 1,395 |
| Start date | Jun 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jun 26, 2006 |
| Last update posted | Dec 5, 2016 |
| Countries | Burkina Faso, Ghana, Kenya, Nigeria, Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: